{"id":60071,"date":"2022-03-22T15:09:07","date_gmt":"2022-03-22T14:09:07","guid":{"rendered":"https:\/\/www.echosens.com\/current-perspectives-in-nafld-nash-identification-management-a-diabetologists-perspective\/"},"modified":"2022-04-01T11:10:45","modified_gmt":"2022-04-01T09:10:45","slug":"diagnostic-et-prise-en-charge-de-la-nafld-nash-le-point-de-vue-du-diabetologue","status":"publish","type":"post","link":"https:\/\/www.echosens.com\/fr\/diagnostic-et-prise-en-charge-de-la-nafld-nash-le-point-de-vue-du-diabetologue\/","title":{"rendered":"Diagnostic et prise en charge de la NAFLD\/NASH Le point de vue du diab\u00e9tologue."},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"","protected":false},"author":2,"featured_media":60076,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_searchwp_excluded":"","footnotes":""},"categories":[48],"tags":[],"class_list":["post-60071","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-webinar-fr","topic-clinique"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Diagnostic et prise en charge de la NAFLD\/NASH Le point de vue du diab\u00e9tologue. - Echosens<\/title>\n<meta name=\"description\" content=\"Diagnostic et prise en charge de la NAFLD\/NASH Le point de vue du diab\u00e9tologue. . Echosens manufactures FibroScan\u00ae, a non-invasive solution that accurately measures liver stiffness and liver steatosis for a comprehensive management of liver disease.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.echosens.com\/fr\/diagnostic-et-prise-en-charge-de-la-nafld-nash-le-point-de-vue-du-diabetologue\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Diagnostic et prise en charge de la NAFLD\/NASH Le point de vue du diab\u00e9tologue. - Echosens\" \/>\n<meta property=\"og:description\" content=\"Diagnostic et prise en charge de la NAFLD\/NASH Le point de vue du diab\u00e9tologue. . Echosens manufactures FibroScan\u00ae, a non-invasive solution that accurately measures liver stiffness and liver steatosis for a comprehensive management of liver disease.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.echosens.com\/fr\/diagnostic-et-prise-en-charge-de-la-nafld-nash-le-point-de-vue-du-diabetologue\/\" \/>\n<meta property=\"og:site_name\" content=\"Echosens\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/fibroscan.echosens\" \/>\n<meta property=\"article:published_time\" content=\"2022-03-22T14:09:07+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-04-01T09:10:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.echosens.com\/wp-content\/uploads\/2022\/03\/Graphic-SMA-diabetes-mars-FR.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1096\" \/>\n\t<meta property=\"og:image:height\" content=\"567\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Alice Alzon\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@Echosens\" \/>\n<meta name=\"twitter:site\" content=\"@Echosens\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Alice Alzon\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.echosens.com\/fr\/diagnostic-et-prise-en-charge-de-la-nafld-nash-le-point-de-vue-du-diabetologue\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.echosens.com\/fr\/diagnostic-et-prise-en-charge-de-la-nafld-nash-le-point-de-vue-du-diabetologue\/\"},\"author\":{\"name\":\"Alice Alzon\",\"@id\":\"https:\/\/www.echosens.com\/fr\/#\/schema\/person\/cd9e21f092270794d3ea967f98f2a227\"},\"headline\":\"Diagnostic et prise en charge de la NAFLD\/NASH Le point de vue du diab\u00e9tologue.\",\"datePublished\":\"2022-03-22T14:09:07+00:00\",\"dateModified\":\"2022-04-01T09:10:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.echosens.com\/fr\/diagnostic-et-prise-en-charge-de-la-nafld-nash-le-point-de-vue-du-diabetologue\/\"},\"wordCount\":16,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.echosens.com\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.echosens.com\/fr\/diagnostic-et-prise-en-charge-de-la-nafld-nash-le-point-de-vue-du-diabetologue\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.echosens.com\/wp-content\/uploads\/2022\/03\/Graphic-SMA-diabetes-mars-FR.jpg\",\"articleSection\":[\"Webinar\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.echosens.com\/fr\/diagnostic-et-prise-en-charge-de-la-nafld-nash-le-point-de-vue-du-diabetologue\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.echosens.com\/fr\/diagnostic-et-prise-en-charge-de-la-nafld-nash-le-point-de-vue-du-diabetologue\/\",\"url\":\"https:\/\/www.echosens.com\/fr\/diagnostic-et-prise-en-charge-de-la-nafld-nash-le-point-de-vue-du-diabetologue\/\",\"name\":\"Diagnostic et prise en charge de la NAFLD\/NASH Le point de vue du diab\u00e9tologue. - Echosens\",\"isPartOf\":{\"@id\":\"https:\/\/www.echosens.com\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.echosens.com\/fr\/diagnostic-et-prise-en-charge-de-la-nafld-nash-le-point-de-vue-du-diabetologue\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.echosens.com\/fr\/diagnostic-et-prise-en-charge-de-la-nafld-nash-le-point-de-vue-du-diabetologue\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.echosens.com\/wp-content\/uploads\/2022\/03\/Graphic-SMA-diabetes-mars-FR.jpg\",\"datePublished\":\"2022-03-22T14:09:07+00:00\",\"dateModified\":\"2022-04-01T09:10:45+00:00\",\"description\":\"Diagnostic et prise en charge de la NAFLD\/NASH Le point de vue du diab\u00e9tologue. . Echosens manufactures FibroScan\u00ae, a non-invasive solution that accurately measures liver stiffness and liver steatosis for a comprehensive management of liver disease.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.echosens.com\/fr\/diagnostic-et-prise-en-charge-de-la-nafld-nash-le-point-de-vue-du-diabetologue\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.echosens.com\/fr\/diagnostic-et-prise-en-charge-de-la-nafld-nash-le-point-de-vue-du-diabetologue\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.echosens.com\/fr\/diagnostic-et-prise-en-charge-de-la-nafld-nash-le-point-de-vue-du-diabetologue\/#primaryimage\",\"url\":\"https:\/\/www.echosens.com\/wp-content\/uploads\/2022\/03\/Graphic-SMA-diabetes-mars-FR.jpg\",\"contentUrl\":\"https:\/\/www.echosens.com\/wp-content\/uploads\/2022\/03\/Graphic-SMA-diabetes-mars-FR.jpg\",\"width\":1096,\"height\":567},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.echosens.com\/fr\/diagnostic-et-prise-en-charge-de-la-nafld-nash-le-point-de-vue-du-diabetologue\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.echosens.com\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Diagnostic et prise en charge de la NAFLD\/NASH Le point de vue du diab\u00e9tologue.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.echosens.com\/fr\/#website\",\"url\":\"https:\/\/www.echosens.com\/fr\/\",\"name\":\"Echosens\",\"description\":\"Un site utilisant WordPress\",\"publisher\":{\"@id\":\"https:\/\/www.echosens.com\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.echosens.com\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.echosens.com\/fr\/#organization\",\"name\":\"ECHOSENS\",\"url\":\"https:\/\/www.echosens.com\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.echosens.com\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.echosens.com\/wp-content\/uploads\/2020\/12\/logo.svg\",\"contentUrl\":\"https:\/\/www.echosens.com\/wp-content\/uploads\/2020\/12\/logo.svg\",\"width\":1,\"height\":1,\"caption\":\"ECHOSENS\"},\"image\":{\"@id\":\"https:\/\/www.echosens.com\/fr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/fibroscan.echosens\",\"https:\/\/x.com\/Echosens\",\"https:\/\/www.linkedin.com\/company\/echosens\/\",\"https:\/\/www.youtube.com\/channel\/UC1myqoq18t1dKPTz0u1eEgg\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.echosens.com\/fr\/#\/schema\/person\/cd9e21f092270794d3ea967f98f2a227\",\"name\":\"Alice Alzon\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/ca270b72d26f95f546f067071651cf5fa8a116873185ef6cf5f6300fcd46e931?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ca270b72d26f95f546f067071651cf5fa8a116873185ef6cf5f6300fcd46e931?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ca270b72d26f95f546f067071651cf5fa8a116873185ef6cf5f6300fcd46e931?s=96&d=mm&r=g\",\"caption\":\"Alice Alzon\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Diagnostic et prise en charge de la NAFLD\/NASH Le point de vue du diab\u00e9tologue. - Echosens","description":"Diagnostic et prise en charge de la NAFLD\/NASH Le point de vue du diab\u00e9tologue. . Echosens manufactures FibroScan\u00ae, a non-invasive solution that accurately measures liver stiffness and liver steatosis for a comprehensive management of liver disease.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.echosens.com\/fr\/diagnostic-et-prise-en-charge-de-la-nafld-nash-le-point-de-vue-du-diabetologue\/","og_locale":"fr_FR","og_type":"article","og_title":"Diagnostic et prise en charge de la NAFLD\/NASH Le point de vue du diab\u00e9tologue. - Echosens","og_description":"Diagnostic et prise en charge de la NAFLD\/NASH Le point de vue du diab\u00e9tologue. . Echosens manufactures FibroScan\u00ae, a non-invasive solution that accurately measures liver stiffness and liver steatosis for a comprehensive management of liver disease.","og_url":"https:\/\/www.echosens.com\/fr\/diagnostic-et-prise-en-charge-de-la-nafld-nash-le-point-de-vue-du-diabetologue\/","og_site_name":"Echosens","article_publisher":"https:\/\/www.facebook.com\/fibroscan.echosens","article_published_time":"2022-03-22T14:09:07+00:00","article_modified_time":"2022-04-01T09:10:45+00:00","og_image":[{"width":1096,"height":567,"url":"https:\/\/www.echosens.com\/wp-content\/uploads\/2022\/03\/Graphic-SMA-diabetes-mars-FR.jpg","type":"image\/jpeg"}],"author":"Alice Alzon","twitter_card":"summary_large_image","twitter_creator":"@Echosens","twitter_site":"@Echosens","twitter_misc":{"\u00c9crit par":"Alice Alzon"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.echosens.com\/fr\/diagnostic-et-prise-en-charge-de-la-nafld-nash-le-point-de-vue-du-diabetologue\/#article","isPartOf":{"@id":"https:\/\/www.echosens.com\/fr\/diagnostic-et-prise-en-charge-de-la-nafld-nash-le-point-de-vue-du-diabetologue\/"},"author":{"name":"Alice Alzon","@id":"https:\/\/www.echosens.com\/fr\/#\/schema\/person\/cd9e21f092270794d3ea967f98f2a227"},"headline":"Diagnostic et prise en charge de la NAFLD\/NASH Le point de vue du diab\u00e9tologue.","datePublished":"2022-03-22T14:09:07+00:00","dateModified":"2022-04-01T09:10:45+00:00","mainEntityOfPage":{"@id":"https:\/\/www.echosens.com\/fr\/diagnostic-et-prise-en-charge-de-la-nafld-nash-le-point-de-vue-du-diabetologue\/"},"wordCount":16,"commentCount":0,"publisher":{"@id":"https:\/\/www.echosens.com\/fr\/#organization"},"image":{"@id":"https:\/\/www.echosens.com\/fr\/diagnostic-et-prise-en-charge-de-la-nafld-nash-le-point-de-vue-du-diabetologue\/#primaryimage"},"thumbnailUrl":"https:\/\/www.echosens.com\/wp-content\/uploads\/2022\/03\/Graphic-SMA-diabetes-mars-FR.jpg","articleSection":["Webinar"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.echosens.com\/fr\/diagnostic-et-prise-en-charge-de-la-nafld-nash-le-point-de-vue-du-diabetologue\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.echosens.com\/fr\/diagnostic-et-prise-en-charge-de-la-nafld-nash-le-point-de-vue-du-diabetologue\/","url":"https:\/\/www.echosens.com\/fr\/diagnostic-et-prise-en-charge-de-la-nafld-nash-le-point-de-vue-du-diabetologue\/","name":"Diagnostic et prise en charge de la NAFLD\/NASH Le point de vue du diab\u00e9tologue. - Echosens","isPartOf":{"@id":"https:\/\/www.echosens.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.echosens.com\/fr\/diagnostic-et-prise-en-charge-de-la-nafld-nash-le-point-de-vue-du-diabetologue\/#primaryimage"},"image":{"@id":"https:\/\/www.echosens.com\/fr\/diagnostic-et-prise-en-charge-de-la-nafld-nash-le-point-de-vue-du-diabetologue\/#primaryimage"},"thumbnailUrl":"https:\/\/www.echosens.com\/wp-content\/uploads\/2022\/03\/Graphic-SMA-diabetes-mars-FR.jpg","datePublished":"2022-03-22T14:09:07+00:00","dateModified":"2022-04-01T09:10:45+00:00","description":"Diagnostic et prise en charge de la NAFLD\/NASH Le point de vue du diab\u00e9tologue. . Echosens manufactures FibroScan\u00ae, a non-invasive solution that accurately measures liver stiffness and liver steatosis for a comprehensive management of liver disease.","breadcrumb":{"@id":"https:\/\/www.echosens.com\/fr\/diagnostic-et-prise-en-charge-de-la-nafld-nash-le-point-de-vue-du-diabetologue\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.echosens.com\/fr\/diagnostic-et-prise-en-charge-de-la-nafld-nash-le-point-de-vue-du-diabetologue\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.echosens.com\/fr\/diagnostic-et-prise-en-charge-de-la-nafld-nash-le-point-de-vue-du-diabetologue\/#primaryimage","url":"https:\/\/www.echosens.com\/wp-content\/uploads\/2022\/03\/Graphic-SMA-diabetes-mars-FR.jpg","contentUrl":"https:\/\/www.echosens.com\/wp-content\/uploads\/2022\/03\/Graphic-SMA-diabetes-mars-FR.jpg","width":1096,"height":567},{"@type":"BreadcrumbList","@id":"https:\/\/www.echosens.com\/fr\/diagnostic-et-prise-en-charge-de-la-nafld-nash-le-point-de-vue-du-diabetologue\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.echosens.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Diagnostic et prise en charge de la NAFLD\/NASH Le point de vue du diab\u00e9tologue."}]},{"@type":"WebSite","@id":"https:\/\/www.echosens.com\/fr\/#website","url":"https:\/\/www.echosens.com\/fr\/","name":"Echosens","description":"Un site utilisant WordPress","publisher":{"@id":"https:\/\/www.echosens.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.echosens.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.echosens.com\/fr\/#organization","name":"ECHOSENS","url":"https:\/\/www.echosens.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.echosens.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.echosens.com\/wp-content\/uploads\/2020\/12\/logo.svg","contentUrl":"https:\/\/www.echosens.com\/wp-content\/uploads\/2020\/12\/logo.svg","width":1,"height":1,"caption":"ECHOSENS"},"image":{"@id":"https:\/\/www.echosens.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/fibroscan.echosens","https:\/\/x.com\/Echosens","https:\/\/www.linkedin.com\/company\/echosens\/","https:\/\/www.youtube.com\/channel\/UC1myqoq18t1dKPTz0u1eEgg"]},{"@type":"Person","@id":"https:\/\/www.echosens.com\/fr\/#\/schema\/person\/cd9e21f092270794d3ea967f98f2a227","name":"Alice Alzon","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/ca270b72d26f95f546f067071651cf5fa8a116873185ef6cf5f6300fcd46e931?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/ca270b72d26f95f546f067071651cf5fa8a116873185ef6cf5f6300fcd46e931?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ca270b72d26f95f546f067071651cf5fa8a116873185ef6cf5f6300fcd46e931?s=96&d=mm&r=g","caption":"Alice Alzon"}}]}},"_links":{"self":[{"href":"https:\/\/www.echosens.com\/fr\/wp-json\/wp\/v2\/posts\/60071","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.echosens.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.echosens.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.echosens.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.echosens.com\/fr\/wp-json\/wp\/v2\/comments?post=60071"}],"version-history":[{"count":4,"href":"https:\/\/www.echosens.com\/fr\/wp-json\/wp\/v2\/posts\/60071\/revisions"}],"predecessor-version":[{"id":60140,"href":"https:\/\/www.echosens.com\/fr\/wp-json\/wp\/v2\/posts\/60071\/revisions\/60140"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.echosens.com\/fr\/wp-json\/wp\/v2\/media\/60076"}],"wp:attachment":[{"href":"https:\/\/www.echosens.com\/fr\/wp-json\/wp\/v2\/media?parent=60071"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.echosens.com\/fr\/wp-json\/wp\/v2\/categories?post=60071"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.echosens.com\/fr\/wp-json\/wp\/v2\/tags?post=60071"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}